| Literature DB >> 27387707 |
Jing Gong1, Huan Chen1, Xiao-Yu Liu1, Zhi-Xiu Wang1, Wei Nie1, Yong Qin1.
Abstract
Due to their architectural intricacy and biological significance, the synthesis of polycyclic diterpenes and their biogenetically related alkaloids have been the subject of considerable interest over the last few decades, with progress including the impressive synthesis of several elusive targets. Despite tremendous efforts, conquering the unique structural types of this large natural product family remains a long-term challenge. The arcutane diterpenes and related alkaloids, bearing a congested tetracyclo[5.3.3.0(4,9).0(4,12)]tridecane unit, are included in these unsolved enigmas. Here we report a concise approach to the construction of the core structure of these molecules and the first total synthesis of (±)-atropurpuran. Pivotal features of the synthesis include an oxidative dearomatization/intramolecular Diels-Alder cycloaddition cascade, sequential aldol and ketyl-olefin cyclizations to assemble the highly caged framework, and a chemoselective and stereoselective reduction to install the requisite allylic hydroxyl group in the target molecule.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27387707 PMCID: PMC4941107 DOI: 10.1038/ncomms12183
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Figure 1Three-dimensionally cage-like diterpenes and diterpenoid alkaloids.
(a) Selected members of three related types of diterpenes and their alkaloidal congeners. Among them, the arcutane diterpenes (that is, 3) and arcutine alkaloids (that is, 6), containing a unique tetracyclo[5.3.3.04,9.04,12]tridecane moiety (shown in blue bonds) and two all-carbon bridgehead quaternary centres (C5 and C8), posed formidable synthetic challenges. (b) Recent accomplishments in the total synthesis of complex atisane-type diterpenes and diterpenoid alkaloids. Ac, acetyl; i-Pr, isopropyl.
Figure 2Retrosynthetic analysis of atropurpuran (3).
The key disconnections involve an aldol reaction and a ketyl-olefin cyclization to construct rings E and B, respectively, at a late stage.
Figure 3Access to the core structure for both arcutane diterpenes and arcutine alkaloids.
(a) Conditions: (a) Ph3PCH2OMeCl, t-BuOK, THF, 0 °C; then TMSCl, NaI, MeCN, −18 °C; (b) NaBH4, MeOH, 0 °C, 55% over two steps; (c) acryloyl chloride, Et3N, CH2Cl2, rt; (d) TBAF, THF, rt, 77% over two steps; (e) PIDA, MeOH, 0 °C; then xylene, BHT, 150 °C; 72%; (f) SmI2, THF/MeOH (20:1), rt, 83%; (g) ethylene glycol, TMSCl, CH2Cl2, rt, 91%; (h) EtSH, AlMe3, CH2Cl2, 0 °C to rt; (i) DMP, CH2Cl2, rt, 65% over two steps (72% brsm); (j) 1,3-cyclohexanedione (15), Hantzsch ester, L-proline, CH2Cl2; then TBDPSCl, Et3N, CH2Cl2, rt, 82%; (k) Pd/C, Et3SiH, CH2Cl2, rt, 88%; (l) TBAF, THF, rt, 91% (>20:1 dr); (m) TBSOTf, 2,6-lutidine, CH2Cl2, –40 °C, 90%; (n) SmI2, HMPA, THF/t-BuOH (20:1), rt, 95%. (b) Comparison of the conformational preferences of intermediates 25 and 26. BHT, 2,6-bis(1,1-dimethylethyl)-4-methylphenol; brsm, based on recovered starting material; HMPA, hexamethylphosphoramide; PIDA, iodobenzene diacetate; TBAF, tetra-n-butylammonium fluoride; TBDPSCl, tert-butyl(chloro)diphenylsilane; TBS, tert-butyldimethylsilyl; TBSOTf, tert-butyldimethylsilyl trifluoromethanesulfonate; THF, tetrahydrofuran; TMSCl, chlorotrimethylsilane.
Figure 4Completion of the total synthesis of (±)-atropurpuran (3).
Conditions: (a) SOCl2, Py., 0 °C; (b) TsOH, acetone/H2O (10:1), 40 °C, 67% over two steps; (c) Ph3PCH3Br, t-BuOK, PhMe, rt, 75%; (d) Me3SI, t-BuOK, DMSO, THF, rt, 68%; (e) BF3·OEt2, PhMe, –20 °C, 92%; (f) TBAF, THF, reflux; (g) DMP, CH2Cl2, rt, 76% over two steps (∼1:1 dr); (h) t-BuOK, MeI, t-BuOH, rt; then 3N HCl, THF, 44% (75% brsm, 5:1 dr); (i) SeO2, t-BuO2H, CH2Cl2, 30 °C, 72% (5:1 dr); (j) DMP, CH2Cl2, rt, 76%; (k) NaBH(OMe)3, THF/MeOH (10:1), −30 °C, 85% (20:1 dr). DMP, Dess-Martin periodinane; THF, tetrahydrofuran.